NanoVibronix, Inc. (NAOV)

Market Cap	2.33M
Revenue (ttm)	2.66M
Net Income (ttm)	-5.61M
Shares Out	2.58M
EPS (ttm)	-15.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	724,135
Open	0.9500
Previous Close	0.9802
Day's Range	0.8400 - 0.9500
52-Week Range	0.6669 - 16.2500
Beta	1.76
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2025

About NAOV

NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is design...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: NAOV
• Website: https://www.nanovibronix.com

Financial Performance

In 2024, NanoVibronix's revenue was $2.56 million, an increase of 12.05% compared to the previous year's $2.28 million. Losses were -$3.71 million, -0.16% less than in 2023.